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Background: Long-term follow-up after stent dilation of native and acquired pulmonary
artery stenosis is scarce in the pediatric population. Most cohorts include a myriad of
anatomies and associated conditions. Method: In order to establish objective perform-
ance criteria, we performed a retrospective review of all patients who underwent uni-
lateral pulmonary artery stenting in biventricular physiology at three centers from June
2006 to June 2011. Results: Fifty-eight patients received 60 stents with Palmaz Gene-
sis stent used most commonly (78%). Average age at implantation was 10.46 10.3
years and weight 31.66 21.8 kg. The immediate success rate was 98%, with improve-
ment in minimal diameter from 5.16 2 cm to 10.66 3 cm (P<0.01). There were 10 com-
plications (7 major and 3 minor) and no acute mortality. One-year follow-up studies
were available in 48 patients (83%), including echocardiogram (60%), catheterization
(28%), MRI (29%), and lung perfusion (31%). Follow-up echocardiogram showed mild
increase in stent gradient, from 5.766.7 mm Hg post-procedure to 17.16 11.7 mm Hg.
Follow-up catheterization showed no significant change in minimal stent diameter
(8.862.6 to 7.86 2.3 mm), gradient (7.76 8.4 to 12.66 12.2 mm Hg), or right ventricular
pressures (43.76 9 to 47.76 10.5 mm Hg). Nine patients (16%) underwent scheduled
stent redilation over a period of 12 days to 25 months. Conclusion: In conclusion,
stent implantation shows excellent immediate and 1-year follow-up results with main-
tenance of improved caliber of the stented vessel and lowered right ventricular systolic
pressures. VC 2014 Wiley Periodicals, Inc.
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BACKGROUND
Branch pulmonary artery stenosis is a frequent yet
challenging lesion, seen in both native and acquired
forms. In the pediatric population, it can be seen either
as an isolated lesion, or more commonly associated
with genetic syndromes and other forms of congenital
heart disease. Surgical repair may itself cause or exac-
erbate pulmonary artery stenosis secondary to scar for-
mation, vascular distortion, folding or external
compression, with a recurrence rate of 35–40% [1–3].
Unless treated early in life, long standing stenosis of
one or both pulmonary arteries can lead to poor distal
vascular growth as well as right ventricular hyperten-
sion and progressive pulmonary insufficiency [4–14].
Since the advent of angioplasty and stent implanta-
tion in the late 1980s, there has been a gradual shift
from surgery to a percutaneous approach. To date,
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there are over 20 outcomes publications on the use of
stents to treat pulmonary arteries providing excellent
early results [4–6,14–18]. However, mid- and long-term
follow-up studies evaluating the effects of angioplasty
and stent implantation are scarce [4,14–17]. Outcome
metrics of these publications are not uniform with a
mixture of two ventricle and single ventricle patients,
unilateral and bilateral stenosis as well as serial stenosis
involving various lobar, segmental, and subsegmental
branches rendering difficulty to define accurately objec-
tive performance criteria for this procedure. In order to
limit the variables of the pathology, we analyzed the im-
mediate and 1-year follow-up of stent implantation to
treat biventricular patients with unilateral pulmonary ar-
tery stenosis with the goal to establish objective per-
formance criteria for stent therapy in pulmonary artery
stenosis. In addition, there has been an improvement in
stent technology such that older stents (Palmaz XD
stent) used widely in the 90s have been replaced by
newer stents (Genesis XD and MaxLD stents) in the
2000s. Hence, we only evaluated patients who met the
inclusion criteria within the recent past in order to
assess the outcomes of the newer stents which are being
employed in the current era.
METHOD
A retrospective review was performed of all two
ventricle patients who underwent unilateral pulmonary
artery stenting from June 2006 to June 2011 at three
centers: Texas Children’s Hospital, Children’s Hospital
of Michigan, and the Mayo Clinic. Exclusion criteria
included bilateral or additional distal branch pulmonary
artery angioplasty or stent implantation, concomitant
right ventricle (RV)-pulmonary artery (PA) conduit
intervention, single ventricle physiology with or with-
out palliation, and genetic syndromes associated with
congenital branch pulmonary artery stenosis, e.g. Ala-
gille and Williams syndromes. Procedural success was
based on previously published data for angioplasty
which includes: (1) >50% improvement in vascular di-
ameter, (2) >50% decrease in gradient across the ste-
nosis, (3) >20% reduction in the right ventricle-to-
systemic artery systolic pressure ratio, or (4) a 20%
increase in flow to the affected lung [19].
Demographic data, pre- and post- procedural imag-
ing including echocardiograms, lung perfusion scans,
and cardiac imaging (CTA or MRI when available), as
well as hemodynamic and angiographic data were col-
lected. Stent selection was based on individual and
institutional preference. Continuous data were repre-
sented as mean6 standard deviation. A two-tailed
t-test was used to assess differences amongst continu-
ous data. A P-value of <0.05 was considered statisti-
cally significant.
RESULTS
Patient Profile
One hundred and eighty-eight pulmonary artery stent
implantations were performed in the 5 year period, of
which 58 patients met inclusion criteria in the three
centers from June 2006 to June 2011. The mean age of
the patients was 10.46 10.3 years (51.7% males).
Baseline characteristics of the patients are listed in
Table I. Fifty-six patients had a previous operation for
congenital heart disease, Tetralogy of Fallot being the
most common lesion (52%). Isolated pulmonary steno-
sis without any other form of congenital heart disease
occurred in only five patients (8.6%, Table II). Left
pulmonary artery was involved in 43 patients (74%,
Table I). Sixty stents were implanted in 58 patients,
with Palmaz Genesis stent used most commonly (47
stents, 78%). Other stents used were Covidien (formely
EV3) stents (8 stents, 13%), Valeo premounted stents
(3 stents, 5%), and Palmaz stents (2 stents, 3%).
Cardiac Catheterization Data
The pre- and post- intervention hemodynamic and
angiographic data are listed in Table III. The overall
implantation success rate was 57 in 58 patients (98%);
only one patient had suboptimal result due to stent
TABLE I. Baseline Patient Characteristics at the Time of
Intervention
Pre stent data Mean6 SD
Age (years) 10.46 10.3
Weight (kg) 31.66 21.8
Height (cm) 124.16 33.4
BSA (m2) 16 0.4
Gender (male:female) 30 (52%):28 (48%)
Site (left:right) 43 (74%):15 (26%)
MRI parameters (available in 16 patients)
Indexed RV volume (ml/m2) 123.16 25.7
RV ejection fraction (%) 50.46 6.8
Regurgitant fraction (%) 34.46 16
TABLE II. Primary Diagnosis
Primary diagnosis N (%)
Tetralogy of Fallot 30 (52%)
Pulmonary atresia-VSD 6 (10%)
Truncus arteriosus 3 (5%)
Transposition of the great arteries 2 (3%)
Double outlet right ventricle 2 (3%)
Pulmonary atresia with intact ventricular septum 2 (3%)
Pulmonary stenosis 2 (3%)
Others 11 (19%)
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embolization requiring surgical repair later. A second
patient underwent angioplasty initially but lost wire
position and decision was made to abort the stent pro-
cedure. This patient was brought back to the cath lab
at a later date and underwent successful stent implanta-
tion in the left pulmonary artery (LPA).
The average right ventricular pressure was
44.36 15 mm Hg preintervention, with a RV-to-
femoral artery systolic pressure (FA) ratio of
526 19.5%. Pre- and post-intervention RV-to-FA pres-
sure ratios were obtained in 51 patients, with a signifi-
cant improvement to 44.96 16.4% post-intervention
(P< 0.01). Pre- and post-intervention gradients across
the stenosis were available in 40 patients, showing a
significant improvement from 18.16 10.4 mm Hg at
baseline to 5.86 7 mm Hg post stent implantation
(P< 0.01). Angiographically, the stenotic pulmonary
artery segment improved from 5.16 2 cm to
10.66 3 cm (P< 0.01), with an average of 2316 84%
increase in vessel diameter. When comparing the diam-
eter of the stenotic segment to the contralateral pulmo-
nary artery, the ratio improved from 37.66 16.3% to
84.56 44.1% (P< 0.01, n¼ 46) post stenting.
Complications
There were 10 complication (17%) overall (7 major
and 3 minor) and no acute mortality. Major complica-
tions included stent migration (2), dissection (1), tran-
sient hypotension (1), thrombosis requiring treatment
(2), reperfusion injury (1), and recurrent laryngeal
nerve palsy (1). Minor complications included stent
malposition (1), minor dissection and aneurysm not
requiring treatment (2). Of the two major stent migra-
tions, one had a proximal stent migration but was repo-
sitioned and restented successfully using a second stent
during the same procedure. The other underwent surgi-
cal repair along with conduit revision 4 days later.
There was one instance of minor stent malposition
which had no anatomical or hemodynamic conse-
quence. One patient had a small, contained dissection
post-angioplasty where a stent was used to tack down
the intimal flap. No further complications on follow-up
studies were observed on this patient. One patient had
hypotension during induction of anesthesia requiring
temporary inotropic support for the procedure.
One patient developed a femoral venous thrombus at
the sheath insertion site, which resolved with heparin
therapy. The 1-year follow-up did not reveal any
sequelae. Further complications are noted in Table IV.
Follow-up
The median length of post-procedure hospital stay
was 2 days, ranging from 0 to 60 days. Fifty patients
(85%) had a length of stay 2 days. One patient was
hospitalized for 60 days post-procedure due to pulmo-
nary hypertension and ventricular tachycardia and
eventually expired. The cause of death was unrelated
to the procedure or stent implantation. There were no
other mortalities during the post-procedure hospital
stay.
Some form of follow-up studies one year or later af-
ter the initial procedure were available for 48 patients
(83%). These included echocardiograms, cardiac cathe-
terization, pulmonary perfusion scans, MRI or CT an-
giography. Eight patients (14%) were lost to follow-up
or were transferred back to their primary cardiologist,
outside of the three institutions.
Cardiac Catheterization
Sixteen patients (28%) underwent follow-up cathe-
terization at median follow-up of 14 months (range 3
months to 4 years) post-intervention. This data
excludes the single patient who returned to the cath lab
one day later for repositioning of a malposed stent.
Indications for repeat catheterization included stent
further dilation in nine, for conduit or contralateral pul-
monary artery stenosis in three, elective electrophysiol-
ogy or hemodynamic study in two, and hybrid
approach for redilation at time of reoperation in two.
Follow-up cath data showed no significant decrease in
minimal diameter of the stent (8.86 2.6 to
7.86 2.3 mm, P¼ 0.4, n¼ 8), increase in gradient
TABLE III. Hemodynamic and Angiographic Data at the Time
of Stent Placement
Pre-stenta Post-stenta P value
Right pressure (mm Hg) 44.26 15.5 41.46 14.3 <0.01
RV:FA ratio (%) 52.36 20.2 45.16 16.5 <0.01
MPA:branch PA
gradient (mm Hg)
18.16 10.4 5.86 7 <0.01
Stenosis diameter (mm) 56 1.9 10.76 2.9 <0.01
Stenotic PA:contralateral PA (%) 386 16 846 44 <0.01
aMean6 SD.
TABLE IV. Complications
Complications No. of patients (%)
Major 7 (12%)
Stent migration/embolization requiring treatment 2
Hypotension requiring inotropes 1
Reperfusion injury requiring treatment 1
Suspected thrombus in RVOT 1
Local vascular thrombosis 1
Left recurrent laryngeal nerve injury 1
Minor 3 (5%)
Stent migration 1
Dissection 1
Bradycardia—no treatment required 1
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(7.76 8.4 to 12.66 12.2 mm Hg, P¼ 0.33, n ¼9), or
increase in right ventricular pressures (43.76 9 to
47.76 10.5 mm Hg, P¼ 0.2, n¼ 12). Nine patients
(16%) underwent scheduled serial stent further dilation
over a period of 12 days to 25 months (mean 136 26
months). Two of these were intraoperative interven-
tions at 12 days and 25 months, respectively. In both
cases, the primary indication for the surgery was RV-
PA conduit intervention. There was one stent fracture
noted 1 month after stent redilation (26 months after
initial procedure) with no significant restenosis noted
on follow-up echocardiograms. No other stent fractures
were noted at follow-up.
Echocardiogram
Pre-procedural echocardiograms were available on
54 patients (93%). Majority of the patients had normal
right ventricular function. Of the four patients with no
available pre-procedural echocardiogram data, three
had alternative imaging available (MRI or CT angiog-
raphy), while one patient referred from an outside insti-
tution did not have echocardiogram available for
review.
Echocardiograms at 1 year were available on 35
patients (60%). There was only mild increase in gradi-
ent across the stent from 5.76 6.7 mm Hg post-
procedure to 17.16 11.7 mm Hg upon follow-up
(Table V). Unfortunately, accurate assessment of the
luminal diameter in the stented region was hampered
by artifact in large proportion of the patients.
Cardiac MRI
Cardiac MRI was obtained in 17 (29%) patients prior
to catheterization. Initial right ventricular function was
normal to mildly depressed in all patients, with indexed
right ventricular volume of 123.16 25.7 ml/m2.
Unfortunately, only five of these patients had a follow-
up MRI, obtained 1–2 year after the procedure. Indexed
right ventricular volumes, ejection fraction, and regurgi-
tant fractions remained unchanged upon follow-up.
Assessment of the stented pulmonary artery segment
was not possible due to artifact interference by the me-
tallic stents.
Lung Perfusion Studies
Post-intervention perfusion evaluation was performed
in 24 patients, by nuclear scans (n¼ 18) and MRI
(n¼ 6). Pre- and post-intervention assessment of lung
perfusion was available in 15 patients: by nuclear scan
(4), MRI (5), or a combination of both (6), (26%). Me-
dian follow-up of these 15 patients was 312.5 days
(range 2 days–1070 days). There was a significant
improvement in perfusion in the affected lung from
19.66 9.1% to 35.56 6.1% upon follow-up.
DISCUSSION
Treatment for branch pulmonary artery stenosis
includes surgical repair, angioplasty, and stent implan-
tation. A search of the literature indicates that surgical
reports are scant and results are poor with a recurrence
rate of 35–40% [1–3,20–23]. Angioplasty alone
showed a success rate of 50–60%, with a recurrence
rate of 15% and complication rate of 6–12% [2,19,24].
Recent studies using high pressure and cutting bal-
loons, alone or in combination, have shown promising
results in immediate improvement when used in resist-
ant lesions, especially in younger patients [25–29].
However there remain issues with recoil resulting in
reduced interval growth. Studies evaluating the effects
of stent implantation report success rates as high as
90% [16–18]. However the heterogeneity of pathology
in pulmonary artery stenosis (single vs. biventricular
physiology, proximal vs. distal pulmonary arteries, uni-
lateral vs. bilateral stenoses, post surgical vs. congeni-
tal) renders difficulty in outcome analysis due to the
variable physiology and response of these lesions to
intervention [30]. In our study, we focused on lesions
limited to unilateral, proximal branch pulmonary
arteries in order to provide a more homogenous popu-
lation for analysis. We also limited the study to the
recent past (2006–2011) in order to study the outcomes
of the newer stents being used currently.
The overall technical success rate was 98% amongst
the three centers involved in this study, with significant
improvements in vascular diameter, pressure gradients,
right ventricular pressure along with concomitant
improvement in regional perfusion to the stented lung.
Our study showed an overall 17% procedural compli-
cation rate of which 12% are in the major category.
Review of the literature suggests pulmonary artery
stent complication rates ranging from 10% to 33%
[2,18,31–34]. However, given the diversity of patients,
heterogeneity of pulmonary artery stenoses and
TABLE V. Follow-up at 1 Year
Cath
pre-stenta
Cath
post-stenta
At 1 year
(Echo f/u)a
RV pressure (mm Hg) 44.196 15.28 41.116 14.32 36.086 11.07
RV:arterial
systolic ratio (%)
51.616 19.49 44.926 16.42 34.396 12.36b
Gradient (mm Hg) 19.026 10.45 5.706 6.73 17.126 11.67
Diameter (mm) 5.16 2 10.76 3 9.76 2.7
aMean6 SD.
bArterial pressure based on cuff measurements.
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changing technology and stent implantation techniques
over time, it is difficult to compare complications
between studies.
In our study, the improvement in vessel caliber and
regional perfusion was relatively well-maintained upon
1-year follow-up studies when available (Fig. 1). Fur-
thermore, qualitative analysis of the follow-up studies
showed interval growth of the distal pulmonary vascu-
lature in all but one who required angioplasty later due
to progressive distal stenosis. This phenomenon is also
reported in a study by Takao et al. [35]. In that article,
upper and lower lobar branches on the side of the
stented proximal branch had “catch-up” growth com-
pared to the normal non-stented side in both single and
two ventricle patients. Interestingly, the authors noted
more growth at the lobar level for two ventricle vs.
single ventricle patients. Echocardiographic evaluation
of the stented vessels was the least reliable modality at
follow-up. While peak velocities can be measured
across a proximal branch pulmonary artery stent to
estimate a gradient, it is difficult to interpret the signif-
icance of the gradients in the presence of a contralat-
eral branch pulmonary artery that can accommodate
increased flow. Furthermore, it is difficult to measure
Fig. 1. Example of a left pulmonary artery stenosis associated
with hypoplasia before and after rehabilitation with stent im-
plantation (red arrows). A: Initial diameter was 3 mm. The sys-
tolic right ventricular to systemic artery pressure (RV/FA) ratio
was not significantly elevated (45%). There was wide discrep-
ancy in branch pulmonary artery flow with only 18% flow to
the left lung. B: Following implantation of a Geneis stent
(PG1910), the diameter increased to 9.4 and the RV/FA ratio
decreased to normal range (30%). Left lung flow increased to
21% post-stenting. C: At the 18-month follow-up cath, there
was minimal intimal growth within the stent. The diameter was
9.1 mm and the RV/FA ratio was 38%. D: Following further dila-
tion with a 14 mm balloon, the diameter increased to 9.8 mm,
the gradient was 3 mm Hg. A follow-up MRI now showed 28%
flow to the left lung. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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vessel diameters accurately in the presence of a stent,
especially in larger patients where acoustic windows
are suboptimal. Right ventricular pressures cannot be
accurately measured without tricuspid regurgitation,
but the interventricular septum can be qualitatively
assessed to estimate the degree of right ventricle hyper-
tension. Nevertheless, echocardiography is a useful,
convenient, and non-invasive modality that can offer a
qualitative assessment of the clinical status of the
patient following pulmonary artery stenting. Currently,
this is the standard of care for follow-up testing at
many centers across the country. MRI can provide
accurate information on RV size and function and lung
perfusion but the stainless steel stents obscure the vas-
cular lumen and pulmonary artery diameters cannot be
measured accurately (Fig. 2). Lung perfusion scans
obviously can assess the physiologic effects of the
interventions but cannot provide anatomic data. CT
angiograms can be used to accurately assess intra-stent
diameters but does require additional radiation expo-
sure and does not offer hemodynamic data. The most
complete follow-up assessment of pulmonary artery
stenting remains cardiac catheterization and angiogra-
phy. However, if the patient is doing well clinically
(NYHA status I or II) and there is lack of evidence of
RV hypertension and significant gradients across a
stented pulmonary artery, it would be difficult to jus-
tify subjecting a patient for such an invasive proce-
dure.
Reported stent fracture rates range widely from 3%
to 21% resulting in restenosis but not associated with
any major hemodynamic complications. Redilation
with additional stents appears to be easily accom-
plished [36,37]. In our series, only one stent fracture
was found at the 1-year follow-up.
Limitation
The major limitations of the study include the retro-
spective nature of this study. The diameter measure-
ments were made by the operating attending and
fellows rather than a third party blinded physician.
This data was obtained through catheterization reports
and may contain bias. In addition, there is the differ-
ence in institutional protocols and operator preferences
amongst the three institutions. There was a lack of con-
sistency in pre-cath and follow-up studies between the
institutions and even among operators within an institu-
tion, rendering long-term assessment of vessel growth
difficult. AHA guidelines on indications for pulmonary
artery stenting were published in 2011 [38], but the
guidelines do not define which standard tests to use in
order to establish the hemodynamic and/or anatomy
criteria for stenting nor are there accepted standard
testing at follow up. As such, it is assumed the data
can be derived from a combination of tests including
echocardiography, MRI, pulmonary perfusion scan, or
CT. It is probably the latter reason that has resulted in
the lack of consistency in pre-cath and follow-up labo-
ratory data. Nevertheless, the available data we do
have does show persistent improvement in the diame-
ters of the stented branch pulmonary artery and
improvement in regional perfusion.
CONCLUSION
With the recent improvement in stent design, lower
profile delivery systems and greater range of stent
sizes, stenting has become the preferred treatment of
choice for branch pulmonary stenosis. Our data show
excellent immediate and 1-year follow-up results with
Fig. 2. MRI of same patient before and after LPA stent implantation. A: 3-D rendering showing
severe stenosis and hypoplasia of LPA (red arrow). B, C: Follow-up MRI post LPA stenting
showing “drop-out” artifact in the region of the stented LPA (red arrows). While relative branch
pulmonary artery flow can still be derived, the stented vessel diameter cannot be measured.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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maintenance of improved caliber of the stented vessel
and lower right ventricular systolic pressures. Close
follow-up with echocardiography, MRI, CT angiogra-
phy, or other perfusion studies as well as repeat cathe-
terization may be necessary. In the growing child,
further dilation will be needed until the vessels reach
adult size. For residual or complex stenoses, multiple
procedures will be needed to rehabilitate the pulmonary
vasculature. Longer follow-up will be required to fur-
ther evaluate the impact of stent implantation on vascu-
lar growth and remodeling. Equally important is the
need to standardize pre-cath and follow-up testing in
order to assess the hemodynamic and anatomic changes
over time.
REFERENCES
1. McGoon DC, Kincaid OW. Stenosis of branch pulmonary
arteries: Surgical repairs. Med Clin North Am 1976;48:257–
263.
2. Trant CA Jr, O’Laughlin MP, Ungerleider RM, Garson A Jr.
Cost-effectiveness analysis of stents, balloon angioplasty, and
surgery for the treatment of branch pulmonary artery stenosis.
Pediatr Cardiol 1997;18:339–344.
3. Luhmer I, et al. Coarctation of the pulmonary artery in neo-
nates: Prevalence, diagnosis and surgical treatment. J Thorac
Cardiovasc Surg 1993;106:889–894.
4. Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW,
Freedom RM, Benson LN. Endovascular stents in the pulmonary
circulation: Clinical impact on management and medium-term
follow-up. Circulation 1995;92:881–885.
5. Petit CJ, Gillespie MJ, Harris MA, Seymour TL, Liu TY, Khan
A, Gaynor JW, Rome JJ. Relief of branch pulmonary artery ste-
nosis reduces pulmonary valve insufficiency in a swine model.
J Thorac Cardiovasc Surg 2009;138:382–389.
6. Oyen WJG, van Oort AM, Tanke RB, van Mill GJ,
Aengevaeren WRM, Corstens FHM. Pulmonary perfusion after
endovascular stenting of pulmonary artery stenosis. J Nucl Med
1995;36:2006–2008.
7. Chaturvedi RR, Kilner PJ, White PA, Bishop A, Szwarc R,
Redington AN. Increased airway pressure and simulated branch
pulmonary artery stenosis increase pulmonary regurgitation after
repair of tetralogy of Fallot. Circulation 1997;95:643–649.
8. Garson A Jr, Nihill MR, McNamara DG, Cooley DA. Status of
the adult and adolescent after repair of tetralogy of Fallot. Cir-
culation 1977;59:1232–1240.
9. Hoshina M, Tomita H, Kimura K, Ono Y, Yagihara T, Echigo
S. Factors determining peripheral pulmonary artery stenosis
remodeling in children after percutaneous transluminal balloon
angioplasty. Circ J 2002;66:345–348.
10. Bartolomaeus G, Radtke WA. Patterns of late diameter change
after balloon angioplasty of branch pulmonary artery stenosis:
Evidence for vascular remodeling. Catheter Cardiovasc Interv
2002;56:533–540.
11. Olivetti G, Ricci R, Lagrasta C, Maniga E, Sonnenblick EH,
Anversa P. Cellular basis of wall remodeling in long-term pres-
sure overload-induced right ventricular hypertrophy in rats. Circ
Res 1988;63:648–657.
12. Urashima T, Zhao M, Wagner R, Fajardo G, Farahani S,
Quertermous T, Bernstein D. Molecular and physiological char-
acterization of RV remodeling in a murine model of pulmonary
stenosis. Am J Physiol Heart Circ Physiol 2008;295:H1351–
H1368.
13. Chow MJ, Zou Y, He H, McGowan FX, Zurakowski D, Zhang
Y. Obstruction-induced pulmonary vascular remodeling. J Bio-
mech Eng 2011;133:111009.
14. Takao CM, Hamzeh RK, Connolly D, Ing FF. Impact of stent
implantation on pulmonary artery growth. Catheter Cardiovasc
Interv 2013;82:445–452.
15. Shaffer K, Mullins C, Grifka R, et al. Intravascular stents in
congenital heart disease: Short- and long-term results from a
large single-center experience. J Am Coll Cardiol 1998;31:661–
667.
16. Law MA, Shamszad P, Nugent AW, Justino H, Breinholt JP,
Mullins CE, Ing FF. Pulmonary artery stents: long-term follow-
up. Catheter Cardiovasc Interv 2010;75:757–764.
17. Spadoni I, Giusti S, Bertolaccini P, Maneschi A, Kraft G,
Carminati M. Long-term follow-up of stents implanted to relieve
peripheral pulmonary arterial stenosis: Hemodynamic findings
and results of lung perfusion scanning. Cardiol Young 1999;9:
585–591.
18. Kenny D, Amin Z, Slyder S, Hijazi ZM. Medium-term out-
comes for peripheral pulmonary artery stenting in adults
with congenital heart disease. J Interv Cardiol 2011;24:373–
377.
19. Rothman A, Perry SB, Keane JF, Lock JE. Early results and
follow-up of balloon angioplasty for branch pulmonary artery
stenoses. J Am Coll Cardiol 1990;15:1109–1117.
20. Barbero-Marcial M, Atik E, et al. Reconstruction of stenotic
and nonconfluent pulmonary arteries simultaneously with a
Blalock-Taussig shunt. J Thorac Cardiovasc Surg 1988;95:82–
89.
21. Cohn LH, Sanders JH Jr, Collins JJ Jr. Surgical treatment of
congenital unilateral pulmonary artery stenosis with contralateral
pulmonary hypertension. Am J Cardiol 1976;38:257–260.
22. Fraser CD Jr, Latson LA, Mee RB. Surgical repair of severe
bilateral branch pulmonary artery stenosis. Ann Thorac Surg
1995;59:738–740.
23. Agnoletti G, Boudjemline Y, et al. Surgical reconstruction of
occluded pulmonary arteries in patients with congenital heart
disease: Effects on pulmonary artery growth. Circulation 2004;
109:2314–2318v.
24. Kan JS, Marvin WJ Jr, Bass JL, Muster AJ, Murphy J. Balloon
angioplasty-branch pulmonary artery stenosis: Results from the
Valvuloplasty and Angioplasty of Congenital Anomalies Regis-
try. Am J Cardiol 1990;65:798–801.
25. Gentles TL, Lock JE, Perry SB. High pressure balloon angio-
plasty for branch pulmonary artery stenosis: Early experience. J
Am Coll Cardiol 1993;22:867–872.
26. Bergersen L, Gauvreau K, Justino H, Nugent A, Rome J,
Kreutzer J, Rhodes J, Nykanen D, Zahn E, Latson L, Moore P,
Lock J, Jenkins K. Randomized trial of cutting balloon com-
pared with high-pressure angioplasty for the treatment of re-
sistant pulmonary artery stenosis. Circulation 2011;124:2388–
2396.
27. Sugiyama H, Veldtman GR, Norgard G, Lee KJ, Chaturvedi R,
Benson LN. Bladed balloon angioplasty for peripheral pulmo-
nary artery stenosis. Catheter Cardiovasc Interv 2004;62:71–
77.
28. Magee AG, Wax D, Saiki Y, Rebekya I, Benson LN. Experi-
mental branch pulmonary artery stenosis angioplasty using a
novel cutting balloon. Can J Cardiol 1998;14:1037–1041.
29. Bergersen LJ, Perry SB, Lock JE. Effect of cutting balloon
angioplasty on resistant pulmonary artery stenosis. Am J Cardiol
2003;91:185–189.
Outcomes of Pulmonary Artery Stenting 1129
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
Published on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
30. Bergersen L, Gauvreau K, Lock JE, Jenkins KJ. Recent results
of pulmonary arterial angioplasty: The differences between
proximal and distal lesions. Cardiol Young 2005;15:597–604.
31. Stapleton GE, Hamzeh R, Mullins CE, Zellers TM, Justino H,
Nugent A, Nihill MR, Grifka RG, Ing FF. Simultaneous stent
implantation to treat bifurcation stenoses in the pulmonary
arteries: Initial results and long-term follow up. Catheter Cardio-
vasc Interv 2009;73:557–563.
32. Gonzalez I, Kenny D, Slyder S, Hijazi ZM. Medium and long-
term outcomes after bilateral pulmonary artery stenting in chil-
dren and adults with congenital heart disease. Pediatr Cardiol
2013;34:179–184.
33. Holzer RJ, Gauvreau K, Kreutzer J, Leahy R, Murphy J, Lock
JE, Cheatham JP, Bergersen L. Balloon angioplasty and stenting
of branch pulmonary arteries: Adverse events and procedural
characteristics: Results of a multi-institutional registry. Circ Car-
diovasc Interv 2011;4:287–296.
34. Pass RH, Hsu DT, Garabedian CP, Schiller MS, Jayakumar
KA, Hellenbrand WE. Endovascular stent implantation in pul-
monary arteries of infants and children without the use of a
long vascular sheath. Catheter Cardiovasc Interv 2002;55:505–
509.
35. Takao CM, El-Said H, Connolly, D, Hamzeh RK, Ing FF.
Impact of stent implantation on pulmonary artery growth. Cathe-
ter Cardiovasc Interv 2013;82:445–452.
36. Breinholt JP, Nugent AW, Law MA, Justino H, Mullins CE, Ing
FF. Stent fractures in congenital heart disease. Catheter Cardio-
vasc Interv 2008;72:977–982.
37. McElhinney DB, Bergersen L, Marshall AC. In situ fracture of
stents implanted for relief of pulmonary arterial stenosis in
patients with congenitally malformed hearts. Cardiol Young
2008;18:405–414.
38. Feltes TF, Bacha E, Beekman RH III, Cheatham JP, Feinstein
JA, Gomes AS, Hijazi ZM, Ing FF, de Moor M, Robert Morrow
W, Mullins CE, Taubert KA, Zahn EM. Indications for cardiac
catheterization and intervention in pediatric cardiac disease: A
scientific statement from the American Heart Association. Cir-
culation 2011;123:2607–2652.
1130 Ing et al.
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
Published on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
